Second Primary Cancers in Melanoma Patients Critically Shorten Survival.
Guoqiao ZhengSubhayan ChattopadhyayKristina SundquistJan SundquistAsta FörstiAkseli HemminkiKari HemminkiPublished in: Clinical epidemiology (2020)
The data showed that SPCs are an increasingly common negative prognostic factor for melanoma. Future attempts to improve melanoma survival need to target SPCs.